The first and only
prescription app for MDD
symptoms1

When your adult patients age 22+ want to add to their current ADT, consider Rejoyn, a novel
treatment for MDD symptoms.1

Image
Icon of a phone with a plus sign in the bottom right corner

Complements your care

Rejoyn is a prescription digital therapeutic that works alongside their ADT.2

Image
Icon showing x6 on a calendar to represent 6 weeks of treatment

6-week treatment

Rejoyn is 6 weeks of cognitive-emotional training (CET) exercises and cognitive behavioral therapy (CBT)-based video lessons that patients complete on their smartphone and on their own time.2

Image
Three arrows that are trending down representing a reduction in MDD symptoms

Reduced MDD symptoms

In a clinical trial, adding Rejoyn to ADT reduced MDD symptoms with zero adverse events related to Rejoyn.2

View clinical data

Designed to target dysregulated neural networks
in the brain2

Dysregulation has been associated with MDD2

Image
Brain image

Imaging of patients with depression has shown hyperactivity in emotion centers, like the amygdala, and hypoactivity in cognitive areas, like the prefrontal cortex.2

Dysregulated connectivity between the prefrontal cortex and the amygdala can cause patients to experience impaired cognitive control of emotion.2

Tapping into neuroplastic potential may reduce MDD symptoms2

Image
A brain highlighting the prefrontal cortex and amygdala. A rich color gradient represents the areas' strengthened connection.

The CET brain exercises in Rejoyn are designed to simultaneously activate the amygdala and prefrontal cortex. Repeated coordination of both regions over 6 weeks may strengthen their connection. This is thought to help enhance cognitive control of emotion, which may help reduce depression symptoms.2

Dysregulation has been associated with MDD2

Image
Graphic depicting the amygdala and prefrontal cortex shows how networks can become dysregulated in the brain. A second, nearly-identical graphic is partly shaded in blue that shows how the brain-training exercises help to strengthen connections between the two parts.

Imaging of patients with depression has shown hyperactivity in emotion centers, like the amygdala, and hypoactivity in cognitive areas, like the prefrontal cortex.2

Dysregulated connectivity between the prefrontal cortex and the amygdala can cause patients to experience impaired cognitive control of emotion.2

Tapping into neuroplastic potential may reduce MDD symptoms2

 

The CET brain exercises in Rejoyn are designed to simultaneously activate the amygdala and prefrontal cortex. Repeated coordination of both regions over 6 weeks may strengthen their connection. This is thought to help enhance cognitive control of emotion, which may help reduce depression symptoms.2